Differential sensitivity of alcohol drinking and partner preference to a CRFR1 antagonist in prairie voles and mice

Sheena Potretzke, Meridith T. Robins, Andrey E. Ryabinin

Research output: Contribution to journalArticle

Abstract

Available pharmacotherapies to treat alcohol use disorder (AUD) show limited efficacy. Preclinical studies in mice and rats suggested that antagonists of the corticotropin releasing factor receptor 1 (CRFR1) could be more efficacious for such treatment. However, clinical trials with CRFR1 antagonists were not successful. While a number of potential explanations for this translational failure have been suggested, we hypothesized that the lack of success in clinical trials could be in part due to different neuroanatomical organization of the CRFR1 system in mice and rats versus humans. The CRF system in prairie voles (Microtus ochrogaster), a socially monogamous rodent species, also shows differences in organization from mice and rats. To test our hypothesis, we compared the efficacy of a potent CRFR1 antagonist, CP-376,395, to modulate alcohol drinking in male and female prairie voles versus male and female C57BL/6J mice using an almost identical 2-bottle choice drinking procedure. CP-376,375 (10 and 20 mg/kg, i.p.) significantly decreased alcohol intake (but not alcohol preference) in mice, but not prairie voles. Furthermore, administration of this antagonist (20 mg/kg, i.p.) prior to the partner preference test (PPT) decreased partner preference (PP) in male prairie voles. These findings support our hypothesis that the greater efficacy of CRFR1 antagonists to suppress alcohol consumption in mice and rats versus other mammalian species could be due to the differences in organization of the CRFR1 system between species. They further indicate that activity of the CRFR1 system is necessary for the formation of pair-bonds, but not consumption of high doses of alcohol. Overall, we suggest that testing potential pharmacotherapies should not rely only on studies in mice and rats.

Original languageEnglish (US)
Article number104676
JournalHormones and Behavior
Volume120
DOIs
StatePublished - Apr 2020

Fingerprint

Arvicolinae
Alcohol Drinking
Alcohols
Pair Bond
Clinical Trials
Drug Therapy
Grassland
CRF receptor type 1
Inbred C57BL Mouse
Drinking
Rodentia

Keywords

  • Affiliation
  • Alcohol
  • Animal models
  • Corticotropin-releasing hormone
  • CRH receptor 1
  • Partner preference
  • Prairie vole

ASJC Scopus subject areas

  • Endocrinology
  • Endocrine and Autonomic Systems
  • Behavioral Neuroscience

Cite this

Differential sensitivity of alcohol drinking and partner preference to a CRFR1 antagonist in prairie voles and mice. / Potretzke, Sheena; Robins, Meridith T.; Ryabinin, Andrey E.

In: Hormones and Behavior, Vol. 120, 104676, 04.2020.

Research output: Contribution to journalArticle

@article{66d38239aec94db8a310d8e4a6dfdf2d,
title = "Differential sensitivity of alcohol drinking and partner preference to a CRFR1 antagonist in prairie voles and mice",
abstract = "Available pharmacotherapies to treat alcohol use disorder (AUD) show limited efficacy. Preclinical studies in mice and rats suggested that antagonists of the corticotropin releasing factor receptor 1 (CRFR1) could be more efficacious for such treatment. However, clinical trials with CRFR1 antagonists were not successful. While a number of potential explanations for this translational failure have been suggested, we hypothesized that the lack of success in clinical trials could be in part due to different neuroanatomical organization of the CRFR1 system in mice and rats versus humans. The CRF system in prairie voles (Microtus ochrogaster), a socially monogamous rodent species, also shows differences in organization from mice and rats. To test our hypothesis, we compared the efficacy of a potent CRFR1 antagonist, CP-376,395, to modulate alcohol drinking in male and female prairie voles versus male and female C57BL/6J mice using an almost identical 2-bottle choice drinking procedure. CP-376,375 (10 and 20 mg/kg, i.p.) significantly decreased alcohol intake (but not alcohol preference) in mice, but not prairie voles. Furthermore, administration of this antagonist (20 mg/kg, i.p.) prior to the partner preference test (PPT) decreased partner preference (PP) in male prairie voles. These findings support our hypothesis that the greater efficacy of CRFR1 antagonists to suppress alcohol consumption in mice and rats versus other mammalian species could be due to the differences in organization of the CRFR1 system between species. They further indicate that activity of the CRFR1 system is necessary for the formation of pair-bonds, but not consumption of high doses of alcohol. Overall, we suggest that testing potential pharmacotherapies should not rely only on studies in mice and rats.",
keywords = "Affiliation, Alcohol, Animal models, Corticotropin-releasing hormone, CRH receptor 1, Partner preference, Prairie vole",
author = "Sheena Potretzke and Robins, {Meridith T.} and Ryabinin, {Andrey E.}",
year = "2020",
month = "4",
doi = "10.1016/j.yhbeh.2020.104676",
language = "English (US)",
volume = "120",
journal = "Hormones and Behavior",
issn = "0018-506X",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Differential sensitivity of alcohol drinking and partner preference to a CRFR1 antagonist in prairie voles and mice

AU - Potretzke, Sheena

AU - Robins, Meridith T.

AU - Ryabinin, Andrey E.

PY - 2020/4

Y1 - 2020/4

N2 - Available pharmacotherapies to treat alcohol use disorder (AUD) show limited efficacy. Preclinical studies in mice and rats suggested that antagonists of the corticotropin releasing factor receptor 1 (CRFR1) could be more efficacious for such treatment. However, clinical trials with CRFR1 antagonists were not successful. While a number of potential explanations for this translational failure have been suggested, we hypothesized that the lack of success in clinical trials could be in part due to different neuroanatomical organization of the CRFR1 system in mice and rats versus humans. The CRF system in prairie voles (Microtus ochrogaster), a socially monogamous rodent species, also shows differences in organization from mice and rats. To test our hypothesis, we compared the efficacy of a potent CRFR1 antagonist, CP-376,395, to modulate alcohol drinking in male and female prairie voles versus male and female C57BL/6J mice using an almost identical 2-bottle choice drinking procedure. CP-376,375 (10 and 20 mg/kg, i.p.) significantly decreased alcohol intake (but not alcohol preference) in mice, but not prairie voles. Furthermore, administration of this antagonist (20 mg/kg, i.p.) prior to the partner preference test (PPT) decreased partner preference (PP) in male prairie voles. These findings support our hypothesis that the greater efficacy of CRFR1 antagonists to suppress alcohol consumption in mice and rats versus other mammalian species could be due to the differences in organization of the CRFR1 system between species. They further indicate that activity of the CRFR1 system is necessary for the formation of pair-bonds, but not consumption of high doses of alcohol. Overall, we suggest that testing potential pharmacotherapies should not rely only on studies in mice and rats.

AB - Available pharmacotherapies to treat alcohol use disorder (AUD) show limited efficacy. Preclinical studies in mice and rats suggested that antagonists of the corticotropin releasing factor receptor 1 (CRFR1) could be more efficacious for such treatment. However, clinical trials with CRFR1 antagonists were not successful. While a number of potential explanations for this translational failure have been suggested, we hypothesized that the lack of success in clinical trials could be in part due to different neuroanatomical organization of the CRFR1 system in mice and rats versus humans. The CRF system in prairie voles (Microtus ochrogaster), a socially monogamous rodent species, also shows differences in organization from mice and rats. To test our hypothesis, we compared the efficacy of a potent CRFR1 antagonist, CP-376,395, to modulate alcohol drinking in male and female prairie voles versus male and female C57BL/6J mice using an almost identical 2-bottle choice drinking procedure. CP-376,375 (10 and 20 mg/kg, i.p.) significantly decreased alcohol intake (but not alcohol preference) in mice, but not prairie voles. Furthermore, administration of this antagonist (20 mg/kg, i.p.) prior to the partner preference test (PPT) decreased partner preference (PP) in male prairie voles. These findings support our hypothesis that the greater efficacy of CRFR1 antagonists to suppress alcohol consumption in mice and rats versus other mammalian species could be due to the differences in organization of the CRFR1 system between species. They further indicate that activity of the CRFR1 system is necessary for the formation of pair-bonds, but not consumption of high doses of alcohol. Overall, we suggest that testing potential pharmacotherapies should not rely only on studies in mice and rats.

KW - Affiliation

KW - Alcohol

KW - Animal models

KW - Corticotropin-releasing hormone

KW - CRH receptor 1

KW - Partner preference

KW - Prairie vole

UR - http://www.scopus.com/inward/record.url?scp=85077922226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077922226&partnerID=8YFLogxK

U2 - 10.1016/j.yhbeh.2020.104676

DO - 10.1016/j.yhbeh.2020.104676

M3 - Article

C2 - 31927017

AN - SCOPUS:85077922226

VL - 120

JO - Hormones and Behavior

JF - Hormones and Behavior

SN - 0018-506X

M1 - 104676

ER -